[Enalapril, atenolol and hydrochlorothiazide in mild or moderate hypertension. A comparative multicenter trial in general practice in Norway]. 1987

A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009664 Norway A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo. Kingdom of Norway
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
April 1988, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
June 1989, Cardiovascular drugs and therapy,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
July 1986, Lancet (London, England),
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
April 1989, The American journal of medicine,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
September 1988, Drug intelligence & clinical pharmacy,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
November 1985, The New Zealand medical journal,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
December 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
February 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
January 1993, The British journal of clinical practice,
A Helgeland, and R Strømmen, and C H Hagelund, and S Tretli
January 1977, Current medical research and opinion,
Copied contents to your clipboard!